TCBP logo

TC Biopharm (Holdings) (TCBP)

Profile

Full Name

TC Biopharm (Holdings) Plc

Ticker Symbol

TCBP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

February 11, 2022

Indexes

Not included

Website

http://tcbiopharm.com

Employees

41

Key Details

Price

$0.38(-18.85%)

Market cap

$192.38K(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3822.56(+49.50% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.38
TCBP price is $0.38

30-Day Relative Volume

0.59
TCBP 30-day relative volume is 0.59

Price Performance

Price Most recent change

-18.85%
TCBP price was down -18.85% on Apr 15, 2025

Price YTD change

-97.09%
TCBP price is down -97.09% since January 1st

Price 1-year change

-99.86%
TCBP price is down -99.86% year-on-year

Price 3-year change

-100%
TCBP price is down -100% over the past 3 years

Price Range

Price All-time high

$4240000.00
TCBP price is currently -100.00% below its historical high of $4240000.00

Price 3-year low

$0.08
TCBP price is currently +368.75% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$192.38K
TCBP market capitalization is $192.38 thousand

Market cap 3-year change

-99.96%
TCBP market capitalization is down -99.96% over the past 3 years

Market cap All-time high

$848.00M
TCBP market capitalization is currently -99.98% below its historical high of $848.00 million

Market cap sector rank

2.3%
TCBP market capitalization is higher than 2.3% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2465%
TCBP shares outstanding is up +2465% year-on-year

Shares Outstanding 3-Year Change

+256400%
TCBP shares outstanding is up +256400% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-1.00
TCBP beta is -1.00

200-day SMA

$55.17
TCBP price is currently -99.32% below its 200-day simple moving average

50-day SMA

$1.75
TCBP price is currently -78.56% below its 50-day simple moving average

RSI

32.39
TCBP 14-day relative strength index is 32.39

Volume

0.59
TCBP 30-day relative volume is 0.59

ATR

$0.28
TCBP average true range is $0.28

10-day Historical Volatility

521.77%
TCBP 10-day historical volatility is 521.77%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
TCBP annual revenue value is unknown

Revenue Analysts estimate

-
TCBP annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
TCBP annual revenue 1-year change is unknown

Revenue Sector rank

-
TCBP annual revenue is unknown

EPS

EPS

-$3822.56
TCBP annual earnings per share is -$3822.56

EPS Analysts estimate

-
TCBP annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+49.5%
TCBP annual earnings per share is up +49.5% year-on-year

EPS Sector rank

0.25%
TCBP annual earnings per share is higher than 0.25% of companies in Healthcare sector

Profit

Gross profit

-
TCBP annual gross profit value is unknown

Gross margin

-
TCBP annual gross profit margin value is unknown

Operating profit

-$17.72M
TCBP annual operating income is -$17.72 million

Operating margin

-
TCBP annual operating profit margin value is unknown

Net income

-$7.35M
TCBP annual net profit is -$7.35 million

Net margin

-
TCBP annual net profit margin value is unknown

Expenses

Total expenses

$17.72M
TCBP annual total expenses is $17.72 million

Operating expenses

$17.72M
TCBP annual total operating expenses is $17.72 million

Cost of goods sold

-
TCBP annual cost of goods sold value is unknown

Selling, general & administrative expenses

$8.05M
TCBP annual SGA is $8.05 million

Depreciation and amortization

$787.70K
TCBP annual depreciation & amortization is $787.70 thousand

Interest expense

$103.30K
TCBP annual interest expense is $103.30 thousand

Income tax

-$1.35M
TCBP annual income tax is -$1.35 million

EBIT & EBITDA

EBIT

-$8.60M
TCBP annual earnings before interest & taxes is -$8.60 million

EBITDA

-$7.81M
TCBP annual EBITDA is -$7.81 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$11.38M
TCBP annual total assets is $11.38 million

Non current assets

$4.12M
TCBP annual long term assets is $4.12 million

Current assets

$7.26M
TCBP annual total current assets is $7.26 million

Cash and cash equivalents

$3.14M
TCBP annual cash & cash equivalents is $3.14 million

Accounts receivable

-
TCBP annual accounts receivable value is unknown

Inventory

-
TCBP annual inventory value is unknown

Liabilities

Total liabilities

$7.96M
TCBP annual total liabilities is $7.96 million

Long term liabilities

$1.91M
TCBP annual total long term liabilities is $1.91 million

Current liabilities

$6.05M
TCBP annual total current liabilities is $6.05 million

Accounts payable

$2.35M
TCBP annual accounts payable is $2.35 million

Debt

Total debt

$2.29M
TCBP annual total debt is $2.29 million

Total debt 1-year change

-31.76%
TCBP annual total debt is down -31.76% year-on-year

Long term debt

$1.91M
TCBP annual long term debt is $1.91 million

Short term debt

$389.00K
TCBP annual short term debt is $389.00 thousand

Equity & Capital

Shareholders equity

$3.42M
TCBP annual stockholders equity is $3.42 million

Book value

$3.42M
TCBP annual book value is $3.42 million

Retained earnings

-$49.47M
TCBP annual retained earnings is -$49.47 million

Working capital

$1.21M
TCBP annual working capital is $1.21 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$13.12M
TCBP annual cash flow from operations is -$13.12 million

Cash from operations 1-year change

+30.71%
TCBP annual cash flow from operations is up +30.71% year-on-year

Cash from investing

-$259.80K
TCBP annual cash flow from investing activities is -$259.80 thousand

Cash from investing 1-year change

+32.36%
TCBP annual cash flow from investing activities is up +32.36% year-on-year

Cash from financing

$10.60M
TCBP annual cash flow from financing activities is $10.60 million

Cash from financing 1-year change

-54.1%
TCBP annual cash flow from financing activities is down -54.1% year-on-year

CAPEX

CAPEX

-
TCBP annual capital expenditures value is unknown

CAPEX 1-year change

-
TCBP annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$13.38M
TCBP annual free cash flow is -$13.38 million

Free cash flow 1-year change

+30.99%
TCBP annual free cash flow is up +30.99% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
TCBP annual gross profit margin value is unknown

Operating margin

-
TCBP annual operating profit margin value is unknown

Net margin

-
TCBP annual net profit margin value is unknown

ROA & ROE

ROA

-64.60%
TCBP annual return on assets is -64.60%

ROE

-214.87%
TCBP annual return on equity is -214.87%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TCBP price to earnings ratio value is unknown

PE ratio Sector rank

-
TCBP price to earnings ratio is unknown

PB Ratio

PB ratio

0.08
TCBP price to book ratio is 0.08

PB ratio Sector rank

17.78%
TCBP price to book ratio is higher than 17.78% of companies in Healthcare sector

PS Ratio

PS ratio

-
TCBP price to sales ratio value is unknown

PS ratio Sector rank

-
TCBP price to sales ratio is unknown

Enterprise value

Enterprise value

$1.01M
TCBP enterprise value is $1.01 million

Enterprise value Sector rank

13.98%
TCBP enterprise value is higher than 13.98% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.15
TCBP EV/EBITDA is -0.15

EV/EBITDA Sector rank

59.79%
TCBP EV/EBITDA is higher than 59.79% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.20
TCBP annual current ratio is 1.20

Quick ratio

-
TCBP annual quick ratio value is unknown

Leverage

Debt to equity

0.67
TCBP annual debt to equity ratio is 0.67

Interest coverage ratio

-83.27
TCBP annual interest coverage ratio is -83.27

Risk & Stability

Piotroski F-Score

-
TCBP piotroski f-score value is unknown

Altman Z-Score

-
TCBP altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Dec 6, 24 HC Wainwright & Co.
Buy
Apr 27, 23 HC Wainwright & Co.
Buy
Jan 26, 23 HC Wainwright & Co.
Buy
Mar 28, 22 EF Hutton
Buy

Institutional Ownership

Similar stocks

CUTR logo
Cutera (CUTR)
KRBP logo
Kiromic BioPharma (KRBP)
IMAC Holdings (BACK)
CYTO logo
Altamira Therapeutics (CYTO)
TCON logo
TRACON Pharmaceuticals (TCON)
RNAZ logo
TransCode Therapeutics (RNAZ)
VRPX logo
Virpax Pharmaceuticals (VRPX)
NAVB logo
Navidea Biopharmaceuticals (NAVB)
NVOS logo
Novo Integrated Sciences (NVOS)
  • What is the ticker symbol for TC Biopharm (Holdings)?
  • Does TC Biopharm (Holdings) pay dividends?
  • What sector is TC Biopharm (Holdings) in?
  • What industry is TC Biopharm (Holdings) in?
  • What country is TC Biopharm (Holdings) based in?
  • When did TC Biopharm (Holdings) go public?
  • Is TC Biopharm (Holdings) in the S&P 500?
  • Is TC Biopharm (Holdings) in the NASDAQ 100?
  • Is TC Biopharm (Holdings) in the Dow Jones?
  • When does TC Biopharm (Holdings) report earnings?

What is the ticker symbol for TC Biopharm (Holdings)?

The ticker symbol for TC Biopharm (Holdings) is NASDAQ:TCBP

Does TC Biopharm (Holdings) pay dividends?

No, TC Biopharm (Holdings) does not pay dividends

What sector is TC Biopharm (Holdings) in?

TC Biopharm (Holdings) is in the Healthcare sector

What industry is TC Biopharm (Holdings) in?

TC Biopharm (Holdings) is in the Biotechnology industry

What country is TC Biopharm (Holdings) based in?

TC Biopharm (Holdings) is headquartered in United Kingdom

When did TC Biopharm (Holdings) go public?

TC Biopharm (Holdings)'s initial public offering (IPO) was on February 11, 2022

Is TC Biopharm (Holdings) in the S&P 500?

No, TC Biopharm (Holdings) is not included in the S&P 500 index

Is TC Biopharm (Holdings) in the NASDAQ 100?

No, TC Biopharm (Holdings) is not included in the NASDAQ 100 index

Is TC Biopharm (Holdings) in the Dow Jones?

No, TC Biopharm (Holdings) is not included in the Dow Jones index

When does TC Biopharm (Holdings) report earnings?

The date for TC Biopharm (Holdings)'s next earnings report has not been announced yet
On this page